A webinar focused on sharing best practices from primary care physicians. The session explores the applications of medical cannabis for chronic pain, fibromyalgia, mood disorders, reducing opioid dependence and benzodiazepines, and more.
El evento inaugural del Capítulo Colombia/Latinoamérica de la Society of Cannabis Clinicians con la participación de investigadores Latinoamericanos. Grabado el viernes 18 de Septiembre 2020.
Ziva Cooper, PhD presents “Controlled Human Laboratory Studies of Cannabis and Cannabinoids: Probing Current Trends in Medicinal Cannabis” at the SCC Quarterly Meeting. Dr. Cooper discusses research examining the differences between men and women in their response to the pain-relieving effects of cannabis, the potential for cannabis to reduce reliance on opioids, and therapeutic effects of cannabinoids in patient populations.
Members of the SCC International Committee share unique and challenging clinical cases from patients using medical cannabis treatment. Originally recorded on June 8th, 2020.
Melanie Dreher, PhD, RN, FAAN gives an in depth account of her groundbreaking anthropological research on the use of cannabis medicine in Jamaica. Recorded in 2018 at Sonoma State University.
A roundtable discussion featuring Society of Cannabis Clinician’s members Dr. Bonni Goldstein, Dr. Dustin Sulak, and Dr. Jeffrey Hergenrather on the applications of cannabis in pediatric care. They share case studies on treating kids and adolescents in their clinical practice with autism, epilepsy, and other conditions.
Explore the applications of cannabis for hospice and palliative care with Valerie Leveroni-Corral. Valerie highlights four case studies and discusses various dosing regimens and protocols that she has used in her work. Valerie is the cofounder of WAMM Phytotherapies, a non-profit organization that has provided cannabis medicine to low income, chronically ill patients for decades.
Know your rights as a cannabis recommending physician. Lawyer Michael Levinsohn outlines legal considerations for healthcare providers in regard to cannabis in clinical practice. He explains the nuances of recommending cannabis in California state which can be useful guidelines for elsewhere.
Kimberly Kirchmeyer of the Medical Board of California discusses the guidelines for recommending cannabis for medicinal purposes. This includes details on patient evaluation, shared decision making, qualifying conditions, treatment agreements, and conflicts of interest.
Dr. Sherry Yafai of the Releaf Institute gives the basics on the endocannabinoid system and cannabinoids. By the end of this lecture, participants will be able to describe the endocannabinoid system and relevant receptors, assess the current clinical evidence for cannabinoids as a therapeutic treatment option, and as well as discussing the need for further education for healthcare providers.
SCC Members Dr. Michelle Sexton and Dr. Jamie Carroon spotlight the applications of cannabis from the naturopathic physician perspective. In this interview, the two discuss the role of the CB2 receptor on immune function and inflammation and how this can alleviate migraines and other conditions.
Dr. Jahan Marcu gives research-based evidence on vape pen use and the EVALI situation, separating fact from conjecture on the vape pen crisis.